Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism, biomarkers and management
Background: Doxorubicin (DOX) is a widely used chemotherapeutic agent that is effective against various solid tumors and hematologic malignancies. However, its clinical application is severely limited by dose-dependent cardiotoxicity, which affects nearly 26% of patients. Objective: This review focu...
Збережено в:
| Автори: | , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Creative Pharma Assent
2024-12-01
|
| Серія: | Journal of Applied Pharmaceutical Research |
| Предмети: | |
| Онлайн доступ: | https://japtronline.com/index.php/joapr/article/view/673 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|